Want to see DSGN full AI Analyst Report?

Design Therapeutics (DSGN) Ownership - Who Owns Design Therapeutics?

108 Followers

Design Therapeutics (DSGN) Ownership Overview

10.98%

Insiders

6.21% Mutual Funds

41.83% Other Institutional Investors

7.40% ETFs

33.57% Public Companies and

Individual Investors

The ownership structure of Design Therapeutics (DSGN) stock is a mix of institutional, retail, and individual investors. Approximately 55.44% of the company’s stock is owned by Institutional Investors, 10.98% is owned by Insiders, and 33.57% is owned by Public Companies and Individual Investors.

The ownership structure of Design Therapeutics (DSGN) stock is a mix of institutional, retail, and individual investors. Approximately 48.04% of the company’s stock is owned by Institutional Investors, 10.98% is owned by Insiders, and 7.40% is owned by Public Companies and Individual Investors.

Recent Hedge Fund Trading Activity

Date	Firm	Activity	Value
Jun 30, 2026	Baker Bros Advisors Lp	xxxxxxxxxxxxx	$38756882
Jun 30, 2026	Driehaus Capital Management Llc	xxxxxxxxxxxxx	$38506334
Jun 30, 2026	Woodline Partners Lp	xxxxxxxxxxxxx	$10134122

Show More Hedge Fund Trading Activity >

Top Shareholders

Holder	# of Shares	Type	% Holding	Value
	6,526,476	Insider	10.43%	98,810,847
Peter Kolchinsky	2,972,973	Institution	4.75%	45,010,811
Felix Baker	2,678,430	Institution	4.28%	40,551,430
Richard Driehaus	2,661,115	Institution	4.25%	40,289,281
	1,840,290	Institution	2.94%	27,861,991
	1,704,822	Institution	2.72%	25,811,005
	1,317,948	Institution	2.11%	19,953,733
Michael Rockefeller	700,354	Institution	1.12%	10,603,360
	616,831	Institution	0.99%	9,338,821
	316,445	Institution	0.51%	4,790,977

Top Mutual Fund Holders

# of Shares	Type	% Holding	Value
1,317,948	Institution	2.11%	19,953,733
616,831	Institution	0.99%	9,338,821
316,445	Institution	0.51%	4,790,977
269,884	Institution	0.43%	4,086,044
258,449	Institution	0.41%	3,912,918
170,048	Institution	0.27%	2,574,527
167,093	Institution	0.27%	2,529,788
137,980	Institution	0.22%	2,089,017
115,451	Institution	0.18%	1,747,928
67,935	Institution	0.11%	1,028,536

Top ETF Holders

Holder	# of Shares	Type	% Holding	Value
Vanguard	1,161,075	Institution	1.86%	14,141,894
iShares	804,099	Institution	1.28%	12,174,059
Vanguard	374,521	Institution	0.60%	4,561,666
iShares	291,212	Institution	0.47%	4,408,950
iShares	280,751	Institution	0.45%	4,250,570
Fidelity	235,657	Institution	0.38%	3,556,064
Vanguard	172,482	Institution	0.28%	2,100,831
Dimensional	156,210	Institution	0.25%	2,357,209
Schwab	153,824	Institution	0.25%	2,321,204
iShares	103,997	Institution	0.17%	1,574,515

FAQ

Who Owns Design Therapeutics (DSGN)?

According to the latest TipRanks data, approximately 41.83% of the company's stock is held by institutional investors, 10.98% is held by insiders, and 33.57% is held by retail investors.

What percentage of Design Therapeutics (DSGN) stock is held by institutional investors?

According to the latest TipRanks data, approximately 41.83% of Design Therapeutics (DSGN) stock is held by institutional investors.

What percentage of Design Therapeutics (DSGN) stock is held by retail investors?

According to the latest TipRanks data, approximately 33.57% of Design Therapeutics (DSGN) stock is held by retail investors.

Who owns the most shares of Design Therapeutics (DSGN)?

Simeon George owns the most shares of Design Therapeutics (DSGN).

What is the significance of the ownership structure for a publicly traded company?

The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.